Nexpoint Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Nexpoint Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-61,856	Closed	-$3.25M	–	200
2020 Q3	$3.25M	Buy	+61,856	New	+$2.56M	0.73%	22

Nexpoint Asset Management's MNTA Position: Q4 2020 in Review

Nexpoint Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 61,856 shares — an estimated $3.25M sold.

Nexpoint Asset Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $3.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Nexpoint Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Nexpoint Asset Management sold 61,856 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.25M.
Nexpoint Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Nexpoint Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $3.25M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Nexpoint Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.